Completion of three-year action plan for site management
Release time:
2021-08-11
2021 , 9 enterprises affiliated to the group company have completed the preparation of the three-year action plan for on-site governance of 2021 - 2023 as required, which will be compiled into a book after being reviewed by the group company and implemented step by step in the second half of the year. site management three-year action plan, that is, starting from
2021, it will take three years to realize the most concise and reasonable 5S management by optimizing the design and reforming the unreasonable site, process and equipment layout. Carry out the renovation and upgrading of each production site link to eliminate leakage and beautify the environment, achieve safe, stable, comfortable and healthy production; standardize on-site visual standards, cleaning standards and greening standards, and create standardized sites; adopt new technologies and new equipment to carry out the construction of digital workshops, improve efficiency, reduce production fluctuations, and reduce employee labor intensity. Improve employees' innovation ability and safety and environmental protection literacy, and create a safe, green and civilized modern factory with peak cultural characteristics. According to the requirements of the group company, each enterprise sorts out the areas to be improved on the work site from
9aspects such as purification and beautification, rectification and management, adding auxiliary equipment, process technology improvement, production equipment improvement, quality control improvement, operation control improvement, safety facilities improvement, and staff quality improvement, each item requires the name of the project, the current defects, the transformation plan, the goal reached after the transformation, the investment budget, the planned implementation time and the responsible person. In order to ensure the orderly and safe implementation of the on-site management projects in the plan, the group company requires that the on-site image transformation projects involved in the implementation of the plan, such as the appearance and color of buildings, general signs, etc., should be implemented according to the group's standardized atlas. If there are no provisions in the standardized atlas, all directly affiliated enterprises should report to the audit performance management department of the group company for coordination and approval, the pharmaceutical subsidiary shall report to the pharmaceutical company for coordination and approval. For the technological transformation projects in the action plan, the application and approval procedures shall be handled separately according to the internal control regulations of the group company. The project plan to be implemented during the year will be further refined and implemented according to the priority of the governance content, so as to save costs and achieve good results. At the same time, the company also requires all units to implement dynamic management of governance projects. According to technological progress or successful governance plans of brother units, the original plan can be appropriately adjusted or increased or decreased. Before the implementation of on-site governance projects, the plan should be well designed, and the governance plan should be formed by pictures, design drawings and words. The project should be implemented according to the standards. After the transformation, the good results should be upgraded to the group company standards and replicated; the group company will also give rewards to enterprises or projects that meet the governance progress and have significant effects as appropriate. (Ni Zhenyu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page